U.S. Banks Stock News

NasdaqGS:AAPL
NasdaqGS:AAPLTech

Is Apple (AAPL) Pricing Reflect Its Growth After Recent Big Tech Sentiment Shift

Wondering whether Apple’s current share price really lines up with its underlying value, or if expectations have simply run ahead of the story you are buying into? Apple’s stock last closed at US$275.50, with returns of 1.7% year to date and 16.8% over the past year. The 7 day return shows a 0.4% decline, which contrasts with a 5.9% gain over the past 30 days, and returns of 79.9% and 116.2% across the last 3 and 5 years respectively. Recent coverage around Apple has continued to focus on...
NasdaqGM:ENPH
NasdaqGM:ENPHSemiconductor

Enphase Energy Expands Home Ecosystem With Bidirectional EV Charging Progress

Enphase Energy (NasdaqGM:ENPH) is advancing its IQ Bidirectional EV Charging Platform with successful technical demonstrations across the US and Europe. The company is validating the platform for grid and home integration, targeting both vehicle to home and vehicle to grid use cases. Enphase is participating in global interoperability events and preparing for volume production as it works to bring the platform to market. Enphase Energy is best known for its microinverters and home energy...
NasdaqGS:GABC
NasdaqGS:GABCBanks

Is German American Bancorp (GABC) Pricing Reflect Its Recent Share Rebound And Earnings Power

If you are wondering whether German American Bancorp is priced fairly at its recent levels, this article will walk through what that share price could imply about value. The stock last closed at US$43.06, with a 7 day return of a 2.6% decline, a 30 day return of 9.2%, and year to date and 1 year returns of 10.8% and 10.1% respectively, which may have caught your eye as you review regional bank names. Recent coverage has focused on German American Bancorp as part of broader discussions about...
NYSE:XYL
NYSE:XYLMachinery

Xylem Sharpens 80 20 Focus As Evoqua Deal Closes And Dividend Rises

Xylem (NYSE:XYL) has completed the integration of its US$7.5b Evoqua acquisition ahead of schedule. The company is launching Phase 2 of its transformation plan with an "80/20" focus on higher quality earnings. Xylem plans to exit certain lower margin and selected international operations, including a retreat from the Chinese market. The board approved an 8% increase in the quarterly dividend, reflecting confidence in financial resilience. Xylem, trading at $126.77, is reshaping its...